Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of OCUP will decline by -29.34% over the next 2 Weeks and hit $0.83 by Wednesday, December 4, 2024. In that time frame, OCUP's share price is expected to range between $0.78 and $0.88.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Dec 4, 2024 | 0.74 | 0.81 | 0.88 |
| Dec 3, 2024 | 0.77 | 0.84 | 0.91 |
| Dec 2, 2024 | 0.78 | 0.85 | 0.91 |
| Nov 29, 2024 | 0.79 | 0.86 | 0.92 |
| Nov 28, 2024 | 0.78 | 0.85 | 0.91 |
| Nov 27, 2024 | 0.82 | 0.89 | 0.96 |
| Nov 26, 2024 | 0.85 | 0.92 | 0.98 |
| Nov 25, 2024 | 0.86 | 0.93 | 1.00 |
| Nov 22, 2024 | 0.88 | 0.94 | 1.01 |
| Nov 21, 2024 | 0.86 | 0.93 | 1.00 |
OCUP shares fell -12.03% in Wednesday, October 23, 2024's trading session, dropping from a previous close of $1.33 to move at $1.17. The stock demonstrated notable intraday movement (see OCUP's key stats for a full breakdown), fluctuating between $1.07 and $1.36, a +26.92% trading range. While recent weeks have seen some volatility, OCUP has managed to secure a +7.34% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 209.86K shares changing hands, 55.88K fewer than the previous session. This amounted to $245.54K in total market activity.
Will OCUP Continue Its Downward Trend?
According to analyst ratings and projections for OCUP, Ocuphire Pharma, Inc. shares are anticipated to decrease by -33.19%, potentially reaching $0.88 per share by December 4, 2024. Short-term technical indicators for OCUP currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 20 negative trading days within the past 30 sessions. Based on the OCUP stock forecast, now is not the best time to buy OCUP stock because its current trading price is +44.77% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on OCUP covering social and institutional perspectives.
OCUP Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into OCUP's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 37.16% to 38.73%) suggest the stock is in a weak bearish momentum phase. The 50-day RSI, at 41.72%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 43.51%, maintains a neutral outlook for the long term. Insights into OCUP's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Ocuphire Pharma, Inc. Monthly Forecast 2024–2025
November 2024
According to our latest forecast models, Ocuphire Pharma, Inc. (OCUP) is positioned to show a strong performance in November 2024. The price is predicted to move between $4.40 and $5.41, settling at an average of $4.86. This could translate to a +315.38% gain.
December 2024
Based on current market signals, Ocuphire Pharma, Inc. is projected to trend december 2024. We forecast a trading range from $4.63 to $5.49, with a likely average price of $5.05. Investors could expect a potential return of +331.62%.
January 2025
Our predictive algorithms indicate Ocuphire Pharma, Inc. stock may see a shift in January 2025. The expected range spans $3.15–$5.05, with an average target of $4.09. This represents a positive outlook and a possible gain of +249.57%.
February 2025
Analyzing established trends, Ocuphire Pharma, Inc. looks set to move in February 2025. Projections place the stock between $2.62 and $3.77, averaging around $3.52. This suggests a +200.85% gain from current levels.
March 2025
Market indicators suggest Ocuphire Pharma, Inc. could experience notable changes during March 2025. Prices could fluctuate within $1.78 to $3.06, with a midpoint forecast of $2.71. The stock might deliver a +131.62% gain.
April 2025
Forecasting for April 2025, models estimate that Ocuphire Pharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $1.44 and $2.79, averaging $2.82. This signals a positive trajectory with potential returns around +141.03%.
May 2025
According to our latest forecast models, Ocuphire Pharma, Inc. (OCUP) is positioned to show a strong performance in May 2025. The price is predicted to move between $0.42 and $2.71, settling at an average of $2.66. This could translate to a +127.35% gain.
June 2025
Based on current market signals, Ocuphire Pharma, Inc. is projected to trend june 2025. We forecast a trading range from $0.00 to $1.61, with a likely average price of $1.88. Investors could expect a potential return of +60.68%.
July 2025
Our predictive algorithms indicate Ocuphire Pharma, Inc. stock may see a shift in July 2025. The expected range spans $0.00–$1.40, with an average target of $2.16. This represents a positive outlook and a possible gain of +84.62%.
August 2025
Analyzing established trends, Ocuphire Pharma, Inc. looks set to move in August 2025. Projections place the stock between $0.00 and $1.08, averaging around $1.89. This suggests a +61.54% gain from current levels.
September 2025
Market indicators suggest Ocuphire Pharma, Inc. could experience notable changes during September 2025. Prices could fluctuate within $0.00 to $0.53, with a midpoint forecast of $1.86. The stock might deliver a +58.97% gain.
October 2025
Forecasting for October 2025, models estimate that Ocuphire Pharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.14, averaging $1.72. This signals a positive trajectory with potential returns around +47.01%.
November 2025
According to our latest forecast models, Ocuphire Pharma, Inc. (OCUP) is positioned to show a strong performance in November 2025. The price is predicted to move between $0.00 and $0.00, settling at an average of $1.43. This could translate to a +22.22% gain.
OCUP's history of dividends and stock splits also plays a role in long-term investor confidence.